Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients (Q36093289)

12 August 2017

1 reference

title

Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients (English)

1 reference

12 August 2017

1 reference

Risto S Cvetković

1

1 reference

PubMed ID

15819597

12 August 2017

Keri Wellington

series ordinal

2

1 reference

12 August 2017

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

65

1 reference

12 August 2017

859-878

1 reference

12 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200565060-00012

12 August 2017

0 references

cites work

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Incremental cost effectiveness of prophylaxis for cytomegalovirus disease in patients with AIDS.

1 reference

12 December 2020

Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.

1 reference

12 December 2020

Ganciclovir. An update of its therapeutic use in cytomegalovirus infection

1 reference

12 December 2020

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

12 December 2020

Formulary considerations for drugs used to prevent cytomegalovirus disease.

1 reference

12 December 2020

Cytomegalovirus prophylaxis in solid organ transplant recipients

1 reference

12 December 2020

Mycophenolate mofetil: a review of its use in the management of solid organ transplantation

1 reference

12 December 2020

Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group

1 reference

12 December 2020

Long-term ganciclovir prophylaxis for successful prevention of primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with CMV-seropositive donors

1 reference

12 December 2020

Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections

1 reference

12 December 2020

Long-term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejection

1 reference

12 December 2020

Fomivirsen: clinical pharmacology and potential drug interactions

1 reference

12 December 2020

1 reference

12 December 2020

Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collabor

1 reference

12 December 2020

Ocular manifestations of HIV/AIDS.

1 reference

12 December 2020

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

1 reference

12 December 2020

Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study

1 reference

12 December 2020

The epidemiology, treatment patterns, and costs of cytomegalovirus retinitis in the post-haart era among a national managed-care population

1 reference

12 December 2020

Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report

1 reference

12 December 2020

1 reference

12 December 2020

Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.

1 reference

12 December 2020

Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation

1 reference

12 December 2020

CytoGam infusions at home.

1 reference

12 December 2020

A systematic review of the associations between dose regimens and medication compliance

1 reference

12 December 2020

Resistance of human cytomegalovirus to antiviral drugs

1 reference

12 December 2020

Prevention of cytomegalovirus disease in recipients of solid-organ transplants

1 reference

12 December 2020

The indirect effects of cytomegalovirus infection on the outcome of organ transplantation

1 reference

12 December 2020

Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.

1 reference

12 December 2020

Infection in organ-transplant recipients

1 reference

12 December 2020

Five-year follow-up of a cohort of profoundly immunosuppressed patients discontinuing therapy for cytomegalovirus retinitis

1 reference

12 December 2020

Intranuclear accumulation of subgenomic noninfectious human cytomegalovirus DNA in infected cells in the presence of ganciclovir

1 reference

12 December 2020

When can cytomegalovirus prophylaxis and maintenance therapy be stopped in HIV disease?

1 reference

12 December 2020

Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group

1 reference

12 December 2020

Antiviral activity and mechanism of action of ganciclovir

1 reference

12 December 2020

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

1 reference

12 December 2020

Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis

1 reference

12 December 2020

Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients

1 reference

12 December 2020

Vaccination against cytomegalovirus, the changeling demon

1 reference

12 December 2020

Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients

1 reference

12 December 2020

Cytomegalovirus Infection in Patients with AIDS

1 reference

12 December 2020

Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects

1 reference

12 December 2020

Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).

1 reference

12 December 2020

The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial

1 reference

12 December 2020

Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS.

1 reference

12 December 2020

Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis

1 reference

12 December 2020

Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients

1 reference

12 December 2020

Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts

1 reference

12 December 2020

Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.

1 reference

12 December 2020

Comparative tolerability of therapies for cytomegalovirus retinitis

1 reference

12 December 2020

A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis.

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

1 reference

12 December 2020

Sustained-release drug implants for the treatment of intraocular disease.

1 reference

12 December 2020

Immune globulin versus antivirals versus combination for prevention of cytomegalovirus disease in transplant recipients

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics of valganciclovir and ganciclovir in renal impairment

1 reference

12 December 2020

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

1 reference

12 December 2020

Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients

1 reference

12 December 2020

10.2165/00003495-200565060-00012

Identifiers

DOI

1 reference

PubMed ID

15819597

Dimensions Publication ID

12 August 2017

0 references

1 reference

PubMed ID

15819597